Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications

Y Liu, W Ding, J Wang, X Ao, J Xue - Frontiers in oncology, 2023 - frontiersin.org
Lung cancer (LC) is a heterogeneous disease with high malignant degree, rapid growth,
and early metastasis. The clinical outcomes of LC patients are generally poor due to the …

microRNAs (miRNAs) in glioblastoma multiforme (GBM)—recent literature review

M Makowska, B Smolarz, H Romanowicz - International Journal of …, 2023 - mdpi.com
Glioblastoma multiforme (GBM) is the most common, malignant, poorly promising primary
brain tumor. GBM is characterized by an infiltrating growth nature, abundant vascularization …

Exploring ncRNA-mediated regulation of EGFR signalling in glioblastoma: From mechanisms to therapeutics

R Thapa, M Afzal, A Goyal, G Gupta, AA Bhat… - Life sciences, 2024 - Elsevier
Glioblastoma (GBM) is the most prevalent and deadly primary brain tumor type, with a
discouragingly low survival rate and few effective treatments. An important function of the …

Unraveling the impact of miR-21 on apoptosis regulation in glioblastoma

MAJ Shaikh, ASA Altamimi, M Afzal, G Gupta… - … -Research and Practice, 2024 - Elsevier
Glioblastoma is a prevalent form of carcinoma that exhibits a greater incidence rate across
diverse demographics globally. Despite extensive global efforts, GBM continues to be a …

Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review

MS Sadeghi, M Lotfi, N Soltani, E Farmani… - Cancer Cell …, 2023 - Springer
Carcinoma of the lung is among the most common types of cancer globally. Concerning its
histology, it is categorized as a non-small cell carcinoma (NSCLC) and a small cell cancer …

Emerging extracellular vesicle-based carriers for glioblastoma diagnosis and therapy

J Wang, Y Liu, F Liu, S Gan, S Roy, I Hasan, B Zhang… - Nanoscale, 2023 - pubs.rsc.org
Glioblastoma (GBM) treatment is still a big clinical challenge because of its highly malignant,
invasive, and lethal characteristics. After treatment with the conventional therapeutic …

Molecular mechanisms of microRNAs in glioblastoma pathogenesis

AB Behrooz, H Latifi-Navid, A Nezhadi, M Świat… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Glioblastoma (GBM) is human's most prevalent and severe brain cancer. Epigenetic
regulators, micro (mi) RNAs, significantly impact cellular health and disease because of their …

miR-200b/MYBL2/CDK1 suppresses proliferation and induces senescence through cell cycle arrest in ovine granulosa cells

P Song, X Chen, P Zhang, Y Zhou, R Zhou - Theriogenology, 2023 - Elsevier
Normal growth of granulosa cells (GCs) is essential for follicular development. miR-200b
plays a vital role in litter size, estrous cycle, ovulation, and follicular development in sheep …

Exploring the role of microRNAs in glioma progression, prognosis, and therapeutic strategies

O Tluli, M Al-Maadhadi, AA Al-Khulaifi, AF Akomolafe… - Cancers, 2023 - mdpi.com
Simple Summary Despite advancements in healthcare and research, the occurrence of
gliomas, a type of brain tumor, continues to rise. Emerging evidence has proven that …

Synergistic effect of cryptotanshinone and temozolomide treatment against human glioblastoma cells

S Zhu, J Guo, L Yu, J Liu, J Chen, J Xin, Y Zhang… - Scientific Reports, 2023 - nature.com
Glioblastoma multiforme (GBM) is a complex disease to treat owing to its profound
chemoresistance. Therefore, we evaluated the combined effect and therapeutic efficacy of …